Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

KY-455: Kyoto Pharm.'s ACAT/lipid peroxidation inhibitor

May 3, 1996

Ligand, Pfizer settle lawsuit related to osteoporosis drugs

May 3, 1996

Teijin reports vitamin D3 derivatives for osteoporosis

May 3, 1996

V-411 approved for marketing in China

April 26, 1996

Pulmonary insulin enters phase II

April 26, 1996

OT-5226: New antidiabetic from Otsuka

April 26, 1996

Amgen presents NESP

April 26, 1996

Three beta3-adrenoceptor agonists in preclinical stage at BMS

April 26, 1996

MTP inhibitor BMS-201038 in development for hyperlipidemia

April 26, 1996

Colestimide NDA filing imminent

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...